Suppr超能文献

由感染艾滋病毒的乌干达孕妇进行艾滋病毒自我检测分发的伴侣检测:一项随机试验。

Partner testing with HIV self-test distribution by Ugandan pregnant women living with HIV: a randomized trial.

机构信息

Infectious Diseases Institute, Makerere University, Kampala, Uganda.

Fred Hutch Cancer Center, Seattle, USA.

出版信息

J Int AIDS Soc. 2023 Sep;26(9):e26156. doi: 10.1002/jia2.26156.

Abstract

INTRODUCTION

Secondary distribution of HIV self-tests (HIVST) by HIV-negative pregnant women to male partners increases men's testing rates. We examined whether this strategy promotes male partner testing for pregnant women living with HIV (PWLHIV).

METHODS

We conducted an open-label individually randomized trial in Kampala, Uganda, in which PWLHIV ≥18 years who reported a partner of unknown HIV status were randomized 2:1 to secondary distribution of HIVST for male partner(s) or standard-of-care (SOC; invitation letter to male partner for fast-track testing). Women were followed until 12 months post-partum. Male partners were offered confirmatory HIV testing and facilitated linkage to antiretroviral treatment (ART) or oral pre-exposure prophylaxis (PrEP). Using intention-to-treat analysis, primary outcomes were male partner testing at the clinic and initiation on PrEP or ART evaluated through 12 months post-partum (ClinicalTrials.gov, NCT03484533).

RESULTS

From November 2018 to March 2020, 500 PWLHIV were enrolled with a median age of 27 years (interquartile range [IQR] 23-30); 332 were randomized to HIVST and 168 to SOC with 437 PWLHIV (87.4%) completing 12 months follow-up post-partum. Of 236 male partners who tested at the clinic and enrolled (47.2%), their median age was 31 years (IQR 27-36), 45 (88.3%) men with HIV started ART and 113 (61.1%) HIV-negative men started PrEP. There was no intervention effect on male partner testing (hazard ratio [HR] 1.04; 95% confidence interval [CI]: 0.79-1.37) or time to ART or PrEP initiation (HR 0.96; 95% CI: 0.69-1.33). Two male partners and two infants acquired HIV for an incidence of 0.99 per 100 person-years (95% CI: 0.12-3.58) and 1.46 per 100 person-years (95% CI: 0.18%-5.28%), respectively. Social harms related to study participation were experienced by six women (HIVST = 5, SOC = 1).

CONCLUSIONS

Almost half of the partners of Ugandan PWLHIV tested for HIV with similar HIV testing rates and linkage to ART or PrEP among the secondary distribution of HIVST and SOC arms. Although half of men became aware of their HIV serostatus and linked to services, additional strategies to reach male partners of women in antenatal care are needed to increase HIV testing and linkage to services among men.

摘要

简介

艾滋病毒阴性孕妇将艾滋病毒自检(HIVST)二次分发给男性伴侣,可提高男性检测率。我们研究了这种策略是否会促进艾滋病毒感染孕妇(PWLHIV)的男性伴侣进行检测。

方法

我们在乌干达坎帕拉进行了一项开放标签、个体随机试验,其中报告伴侣艾滋病毒状况未知的 18 岁及以上 PWLHIV 按 2:1 的比例随机分为二次分发 HIVST 给男性伴侣组或标准护理(SOC;邀请伴侣快速检测)。女性随访至产后 12 个月。男性伴侣提供确认性艾滋病毒检测,并促进他们接受抗逆转录病毒治疗(ART)或口服暴露前预防(PrEP)。采用意向治疗分析,主要结局为产后 12 个月时在诊所进行的男性伴侣检测以及开始使用 PrEP 或 ART 的情况(ClinicalTrials.gov,NCT03484533)。

结果

2018 年 11 月至 2020 年 3 月,共纳入 500 名 PWLHIV,中位年龄为 27 岁(四分位间距 [IQR] 23-30);332 名被随机分配至 HIVST 组,168 名被随机分配至 SOC 组,其中 437 名 PWLHIV(87.4%)完成了产后 12 个月的随访。在接受诊所检测和入组的 236 名男性伴侣中(47.2%),他们的中位年龄为 31 岁(IQR 27-36),45 名(88.3%)艾滋病毒阳性男性开始接受 ART 治疗,113 名(61.1%)艾滋病毒阴性男性开始接受 PrEP。男性伴侣检测(危险比 [HR] 1.04;95%置信区间 [CI]:0.79-1.37)或开始接受 ART 或 PrEP 的时间(HR 0.96;95% CI:0.69-1.33)均无干预效果。有两名男性伴侣和两名婴儿感染了艾滋病毒,发病率分别为每 100 人年 0.99(95% CI:0.12-3.58)和 1.46(95% CI:0.18%-5.28%)。有 6 名妇女(HIVST 组 5 名,SOC 组 1 名)经历了与研究参与相关的社会伤害。

结论

在艾滋病毒自检二次分发和 SOC 组中,乌干达 PWLHIV 的近一半伴侣接受了艾滋病毒检测,且检测率和艾滋病毒检测后接受抗逆转录病毒治疗或暴露前预防的比例相似。尽管一半的男性伴侣了解了他们的艾滋病毒血清状况并获得了服务,但仍需要采取其他策略来接触在产前护理中的妇女的男性伴侣,以提高男性的检测率和获得服务的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0b/10483500/9f3ba781d5fa/JIA2-26-e26156-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验